Skip to main content
. 2020 Jun 25;55(6):2000085. doi: 10.1183/13993003.00085-2020

FIGURE 4.

FIGURE 4

Proportion of subjects who had (a) a relative decline in forced vital capacity (FVC) >10% predicted at Week 52 and (b) a relative decline in FVC >5% predicted at Week 52 in the placebo groups of the INPULSIS and INBUILD trials. Data are expressed as % or OR (95% CI). OR: odds ratio; CI: confidence interval; UIP: usual interstitial pneumonia; HRCT: high-resolution computed tomography.